SD0006: A Potent, Selective and Orally Available Inhibitor of p38 Kinase

By  

Pharmacology, Vol. 84, Iss. 1, 2009-07 ,pp. : 42-60

Karger

Access to resources Recommend Favorite

Optimized 4,5-Diarylimidazoles as Potent/Selective Inhibitors of Protein Kinase CK1δ and Their Structural Relation to p38α MAPK

By Halekotte Jakob   Witt Lydia   Ianes Chiara   Krüger Marc   Bührmann Mike   Rauh Daniel   Pichlo Christian   Brunstein Elena   Luxenburger Andreas   Baumann Ulrich   Knippschild Uwe   Bischof Joachim   Peifer Christian  

Molecules, Vol. 22, Iss. 4, 2017-03 ,pp. : 522-522

MDPI

Access to resources Recommend Favorite

A Diverse and Versatile Regiospecific Synthesis of Tetrasubstituted Alkylsulfanylimidazoles as p38α Mitogen-Activated Protein Kinase Inhibitors

By Ansideri Francesco   Andreev Stanislav   Kuhn Annette   Albrecht Wolfgang   Laufer Stefan A.   Koch Pierre  

Molecules, Vol. 23, Iss. 1, 2018-01 ,pp. : 221-221

MDPI

Access to resources Recommend Favorite

3D-QSAR and Molecular Docking Studies on Fused Pyrazoles as p38α Mitogen-Activated Protein Kinase Inhibitors

By Lan Ping   Huang Zhi-Jian   Sun Jun-Rong   Chen Wei-Min  

International Journal of Molecular Sciences, Vol. 11, Iss. 9, 2010-09 ,pp. : 3357-3374

MDPI

Access to resources Recommend Favorite

Limb Remote Ischemic Postconditioning Reduces Ischemia-Reperfusion Injury by Inhibiting NADPH Oxidase Activation and MyD88-TRAF6-P38MAP-Kinase Pathway of Neutrophils

By Chen Gangling   Ye Xinyi   Zhang Jiangwei   Tang Tingli   Li Lin   Lu Peirong   Wu Qi   Yu Boyang   Kou Junping  

International Journal of Molecular Sciences, Vol. 17, Iss. 12, 2016-11 ,pp. : 1971-1971

MDPI

Access to resources Recommend Favorite